VXRT
Vaxart, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.49
−2.78%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.97x
Trailing multiples
Trailing twelve months
- P/E TTM
- 3.24x
- PEG TTM
- —
- Price / book
- 1.35x
- Price / sales
- 0.46x
- Price / cash flow
- 3.27x
Enterprise value
- Enterprise value
- $55.1M
- EV / sales
- 0.23x
- EV / EBITDA
- 1.17x
- EV / EBIT
- 1.39x
- Market cap
- $111.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026